Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$43.51
+2.1%
$34.99
$27.07
$43.63
$1.77B1.34324,681 shs187,487 shs
CONMED Corporation stock logo
CNMD
CONMED
$47.71
-1.1%
$50.00
$42.50
$78.00
$1.48B1.14345,249 shs349,382 shs
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
$17.03
-0.2%
$19.13
$15.28
$32.00
$427.01M1.02210,652 shs212,934 shs
NovoCure Limited stock logo
NVCR
NovoCure
$13.75
-1.2%
$12.99
$10.87
$34.13
$1.54B0.751.63 million shs1.06 million shs
10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cadre Holdings, Inc. stock logo
CDRE
Cadre
0.00%+6.87%+21.74%+28.52%+16.22%
CONMED Corporation stock logo
CNMD
CONMED
0.00%+5.77%+3.71%-6.32%-23.42%
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
0.00%-1.22%-5.49%-25.14%-34.04%
NovoCure Limited stock logo
NVCR
NovoCure
0.00%-0.22%+7.59%+14.20%-15.02%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$43.51
+2.1%
$34.99
$27.07
$43.63
$1.77B1.34324,681 shs187,487 shs
CONMED Corporation stock logo
CNMD
CONMED
$47.71
-1.1%
$50.00
$42.50
$78.00
$1.48B1.14345,249 shs349,382 shs
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
$17.03
-0.2%
$19.13
$15.28
$32.00
$427.01M1.02210,652 shs212,934 shs
NovoCure Limited stock logo
NVCR
NovoCure
$13.75
-1.2%
$12.99
$10.87
$34.13
$1.54B0.751.63 million shs1.06 million shs
10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cadre Holdings, Inc. stock logo
CDRE
Cadre
0.00%+6.87%+21.74%+28.52%+16.22%
CONMED Corporation stock logo
CNMD
CONMED
0.00%+5.77%+3.71%-6.32%-23.42%
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
0.00%-1.22%-5.49%-25.14%-34.04%
NovoCure Limited stock logo
NVCR
NovoCure
0.00%-0.22%+7.59%+14.20%-15.02%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Cadre Holdings, Inc. stock logo
CDRE
Cadre
2.40
Hold$37.50-13.82% Downside
CONMED Corporation stock logo
CNMD
CONMED
2.00
Hold$59.8025.35% Upside
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
2.67
Moderate Buy$26.2954.35% Upside
NovoCure Limited stock logo
NVCR
NovoCure
2.38
Hold$27.50100.00% Upside

Current Analyst Ratings Breakdown

Latest KIDS, CDRE, NVCR, and CNMD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/25/2025
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
10/25/2025
NovoCure Limited stock logo
NVCR
NovoCure
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
10/24/2025
Cadre Holdings, Inc. stock logo
CDRE
Cadre
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold (C)
10/24/2025
CONMED Corporation stock logo
CNMD
CONMED
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D+)
10/10/2025
Cadre Holdings, Inc. stock logo
CDRE
Cadre
Roth Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$44.00
10/10/2025
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
Truist Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$18.00
10/10/2025
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
Lake Street Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$37.00 ➝ $34.00
10/10/2025
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
BTIG Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$39.00 ➝ $23.00
10/10/2025
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOutperform
10/10/2025
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
JMP Securities
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetMarket Outperform$35.00 ➝ $25.00
10/10/2025
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
Stifel Nicolaus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$32.00 ➝ $20.00
(Data available from 10/26/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$572.61M3.09$1.42 per share30.67$7.67 per share5.67
CONMED Corporation stock logo
CNMD
CONMED
$1.31B1.13$6.71 per share7.11$31.16 per share1.53
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
$204.73M2.09N/AN/A$14.64 per share1.16
NovoCure Limited stock logo
NVCR
NovoCure
$605.22M2.54N/AN/A$3.33 per share4.13
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$36.13M$0.9446.2931.991.576.65%12.08%5.60%11/4/2025 (Confirmed)
CONMED Corporation stock logo
CNMD
CONMED
$132.42M$3.5313.529.411.628.31%14.43%6.05%11/5/2025 (Confirmed)
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
-$37.82M-$1.79N/AN/AN/A-18.92%-6.36%-4.69%10/28/2025 (Estimated)
NovoCure Limited stock logo
NVCR
NovoCure
-$168.63M-$1.56N/AN/AN/A-27.13%-47.74%-13.79%10/30/2025 (Confirmed)

Latest KIDS, CDRE, NVCR, and CNMD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/5/2025Q3 2025
CONMED Corporation stock logo
CNMD
CONMED
$1.06N/AN/AN/A$334.76 millionN/A
11/4/2025Q3 2025
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$0.27N/AN/AN/A$158.96 millionN/A
10/30/2025Q3 2025
NovoCure Limited stock logo
NVCR
NovoCure
-$0.42N/AN/AN/A$158.81 millionN/A
10/28/2025Q3 2025
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
-$0.24N/AN/AN/A$63.63 millionN/A
8/5/2025Q2 2025
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$0.25$0.30+$0.05$0.30$153.23 million$157.11 million
8/5/2025Q2 2025
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
-$0.17-$0.11+$0.06-$0.30$61.40 million$61.08 million
7/30/2025Q2 2025
CONMED Corporation stock logo
CNMD
CONMED
$1.13$1.15+$0.02$0.69$338.42 million$342.35 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$0.380.87%N/A40.43%2 Years
CONMED Corporation stock logo
CNMD
CONMED
$0.801.68%N/A22.66%N/A
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
N/AN/AN/AN/AN/A
NovoCure Limited stock logo
NVCR
NovoCure
N/AN/AN/AN/AN/A

Latest KIDS, CDRE, NVCR, and CNMD Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
10/21/2025
Cadre Holdings, Inc. stock logo
CDRE
Cadre
quarterly$0.09500.92%10/31/202510/31/202511/14/2025
8/7/2025
CONMED Corporation stock logo
CNMD
CONMED
quarterly$0.201.55%9/15/20259/15/202510/3/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Cadre Holdings, Inc. stock logo
CDRE
Cadre
0.90
3.59
2.56
CONMED Corporation stock logo
CNMD
CONMED
0.88
2.23
1.00
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
0.27
6.66
3.43
NovoCure Limited stock logo
NVCR
NovoCure
0.28
1.45
1.39

Institutional Ownership

CompanyInstitutional Ownership
Cadre Holdings, Inc. stock logo
CDRE
Cadre
43.95%
CONMED Corporation stock logo
CNMD
CONMED
N/A
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
69.05%
NovoCure Limited stock logo
NVCR
NovoCure
84.61%

Insider Ownership

CompanyInsider Ownership
Cadre Holdings, Inc. stock logo
CDRE
Cadre
31.50%
CONMED Corporation stock logo
CNMD
CONMED
3.10%
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
32.70%
NovoCure Limited stock logo
NVCR
NovoCure
5.52%
CompanyEmployeesShares OutstandingFree FloatOptionable
Cadre Holdings, Inc. stock logo
CDRE
Cadre
2,28440.66 million27.86 millionOptionable
CONMED Corporation stock logo
CNMD
CONMED
3,90030.95 million30.00 millionOptionable
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
20025.07 million16.88 millionOptionable
NovoCure Limited stock logo
NVCR
NovoCure
1,488111.80 million105.63 millionOptionable

Recent News About These Companies

Evercore ISI Sticks to Their Buy Rating for NovoCure (NVCR)
Novocure to Report Third Quarter 2025 Financial Results
NovoCure's (NVCR) "Neutral" Rating Reaffirmed at Wedbush
Novocure earns Japanese approval for tumor-treating fields
Insider Spends US$997k Buying More Shares In NovoCure

New MarketBeat Followers Over Time

Media Sentiment Over Time

Cadre stock logo

Cadre NYSE:CDRE

$43.51 +0.91 (+2.14%)
Closing price 10/24/2025 03:59 PM Eastern
Extended Trading
$43.47 -0.04 (-0.10%)
As of 10/24/2025 05:23 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Cadre Holdings, Inc. manufactures and distributes safety that provides protection to users in hazardous or life-threatening situations in the United States and internationally. The company operates in two segments, Products and Distribution. It offers body armor product, such as concealable, corrections, and tactical armor under the Safariland and Protech Tactical brand names; survival suits, remotely operated vehicles, specialty tools, blast sensors, accessories, and vehicle blast attenuation seats for bomb safety technicians; bomb suits; duty gear, including belts and accessories; and other protective equipment comprising communications gear, forensic and investigation products, firearms cleaning solutions, and crowd control products. The company also offers third-party products, such as uniforms, optics, boots, firearms, and ammunition. It serves first responders, such as state and local law enforcement, fire and rescue, explosive ordnance disposal technicians, emergency medical technicians, fishing, and wildlife enforcement and departments of corrections, as well as federal agencies including the U.S. Department of State, U.S. Department of Defense, U.S. Department of Interior, U.S. Department of Justice, U.S. Department of Homeland Security, U.S. Department of Corrections, the Department of Energy, Los Alamos National Laboratories, Waste Isolation Plant, and various foreign government agencies. Cadre Holdings, Inc. was founded in 1964 and is headquartered in Jacksonville, Florida.

CONMED stock logo

CONMED NYSE:CNMD

$47.71 -0.55 (-1.14%)
Closing price 10/24/2025 03:59 PM Eastern
Extended Trading
$47.46 -0.24 (-0.51%)
As of 10/24/2025 05:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. The company also provides battery-powered and autoclavable bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under Hall surgical brand name. In addition, it offers general surgery products, including clinical insufflation systems under AirSeal brand; smoke removal devices under Buffalo Filter brand; endomechanical products, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solution comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems and other accessories. Further, the company provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.

OrthoPediatrics stock logo

OrthoPediatrics NASDAQ:KIDS

$17.03 -0.03 (-0.18%)
Closing price 10/24/2025 04:00 PM Eastern
Extended Trading
$17.02 -0.02 (-0.09%)
As of 10/24/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIMTM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIROTM Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, and Mitchell Ponseti. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.

NovoCure stock logo

NovoCure NASDAQ:NVCR

$13.75 -0.17 (-1.22%)
Closing price 10/24/2025 04:00 PM Eastern
Extended Trading
$13.74 -0.02 (-0.11%)
As of 10/24/2025 07:21 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, Japan, Greater China, and internationally. The company's TTFields devices include Optune Gio and Optune Lua. It also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Saint Helier, Jersey.